Tobias Kurth, MD, Sc.D., of the University Pierre et Marie Curie, Paris, and Christophe Tzourio, M.D., Ph.D., of the University Pierre et Marie Curie and Harvard School of Public Health, Boston, write in an accompanying editorial that the clinical implications of this study ". . .should be interpreted with caution."
They continue, "In the absence of the source and the nature of
infarct-like lesions and the absence of clinical symptoms or
consequences, it is premature to conclude that migraine has
hazardous effects on the brain. In this regard, brain scans among
patients with migraine should not be initiated to detect silent
brain lesions but to rule out rare secondary forms of migraine
among those patients with atypical migraine forms or migraine
courses."
SOURCE:
JAMA, June 24, 2009
Want to be the FIRST TO KNOW?
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.
If this story or any other Ivanhoe story has impacted your life or prompted you or someone you know to seek or change treatments, please let us know by contacting Melissa Medalie at mmedalie@ivanhoe.com
